| New dietary guidelines for patients with gout - Video New Findings Along with Simplified Dietary Guidelines to Help Patients Manage Flares Released for Gout Awareness Day, May 22 feedproxy.google.com |
Eli Lilly Profit Rises 16%; Bristol Posts 5.7% Drop Drug maker Eli Lilly reported a 16% increase in second-quarter profit as price increases in the U.S. helped offset pricing pressures abroad. Bristol-Myers reported a 5.7% decline in net income despite slightly higher sales. online.wsj.com |
Insurers Supply IT to Doctors Health insurers including Humana and Aetna are stepping into the race to equip doctors with electronic patient records. online.wsj.com |
Here We Go Again: Novartis Fined for Off-Label Marketing Pharmalot submits: Another week, another drugmaker agrees to settle off-label marketing charges brought by the federal government. This time, Novartis (NVS) will pay $422.5 million for illegally promoting its Trileptal epilepsy med for unapproved uses, such as bipolar disorder and neuropathic pain, along with five other drugs - Diovan, Zelnorm, Sandostatin, Exforge and Tekturna. The fine includes roughly $237 million to settle four lawsuits brought by whistleblowers, while $185 million goes toward criminal penalties. One of the lawsuits was filed by Jeremy Garrity, a former cardiovascular sales rep, who worked for Novartis between 2002 and 2008 before being fired (you can read it here, and another whistleblower suit here, and you can read the settlement here. Oh, and this is the guilty plea [pdf files]). (Update: Read interview with Garrity here.)Complete Story » seekingalpha.com |
Grassley Asks FDA About Firms' Payments to Doctors U.S. Senate investigators are inquiring into whether the FDA polices medical companies' payments to doctors who participate in clinical studies of the companies' medical devices. online.wsj.com |